The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia

被引:10
|
作者
Cetinkaya, Semra [1 ]
Kara, Cengiz [1 ]
机构
[1] Childrens Hlth & Dis Training & Res Hosp, Ankara, Turkey
来源
关键词
bone mineral density; congenital adrenal hyperplasia; glucocorticoids; Turkish children; YOUNG-ADULT PATIENTS; 21-HYDROXYLASE DEFICIENCY; BODY-COMPOSITION; TURNOVER; MARKERS; WOMEN; GROWTH; GIRLS; BOYS; MASS;
D O I
10.1515/JPEM.2011.189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: 1) To evaluate the effects of glucocorticoid (GC) doses on bone mineral density (BMD) in children with congenital adrenal hyperplasia (CAH), 2) Investigate other factors influencing BMD. Methods: Twenty-six children with CAH and 11 healthy controls included in the study. All of the patients were examined with dual-energy X-ray absorptiometry (DXA) using a Hologic QDR 1000/W densitometer. The metabolic control state, age at diagnosis GC dose (mg/m(2)/day), pubertal status, 17 hydroxyprogesterone (17 OHP) levels, bone age (BA), and lumber BMD were evaluated in all cases. BMD (g/cm(2)), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR) values were determined. Patients were grouped according to mean on-therapy serum 17 OHP levels as tight control (17 OHP < 10 nmol/L) (n:13) and poor control (17 OHP > 10 nmol/L) (n: 13). All groups were compared with each other. Results: The age range was 2.1-15.7 years and the mean age (+/- SD) 9.3 (+/- 3.5) years. There were no significant differences between the groups in terms of GC doses, lumbar BMD values [ BMD (g/cm(2)), BMD z-score corrected to National Standards (cNS-BMD z-score), BMD z-score corrected to BA (cBABMD), bone mineral content (BMC), BMC corrected to puberty (cPBMC), and bone area (BAR)]. However, the BMI value was higher in children with CAH than normal healthy controls. The BA of the poor control, late diagnosed groups and male patients were higher than tight control, early diagnosed group and female patients, respectively. BMC and BA were lower than the control group in tight control with early diagnosed patients. The cBABMD z-score was lower in males with poor control than males with tight control. There were no similar results in female patients. Conclusions: Although GC treatment seems not to influence BMD in CAH patients in our study, further studies are needed to additionally evaluate daily calcium (Ca) intake, polymorphism of vitamin D receptor, ethnic factors (strict Islamic dress, etc.), socioeconomic status, and 24-h urinary free cortisol level.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 50 条
  • [31] Bone mineral density in children exposed to chronic glucocorticoid therapy
    Cohran, Valeria C.
    Griffiths, Mark
    Heubi, James E.
    CLINICAL PEDIATRICS, 2008, 47 (05) : 469 - 475
  • [32] EFFECT OF GLUCOCORTICOID REPLACEMENT THERAPY ON BONE-MINERAL DENSITY IN PATIENTS WITH ADDISON-DISEASE
    ZELISSEN, PMJ
    CROUGHS, RJM
    VANRIJK, PP
    RAYMAKERS, JA
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (03) : 207 - 210
  • [33] BONE-MINERAL DENSITY AND BODY-COMPOSITION IN CONGENITAL ADRENAL-HYPERPLASIA
    CAMERON, FJ
    KAYMAKCI, B
    BYRT, EA
    EBELING, PR
    WARNE, GL
    WARK, JD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07): : 2238 - 2243
  • [34] Bone Mineral Density in Patients With Congenital Adrenal Hyperplasia From Prepubertal to Adult Age
    Stancampiano, Marianna Rita
    Pitea, Marco
    Maruca, Katia
    Meroni, Silvia Laura Carla
    Bucolo, Carmen
    Russo, Gianni
    Mora, Stefano
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [35] SERUM MELATONIN IS NOT AFFECTED BY GLUCOCORTICOID REPLACEMENT IN CONGENITAL ADRENAL-HYPERPLASIA
    WALDHAUSER, F
    FRISCH, H
    KRAUTGASSERGASPAROTTI, A
    SCHOBER, E
    BIEGLMAYER, C
    ACTA ENDOCRINOLOGICA, 1986, 111 (03): : 355 - 359
  • [36] Management of congenital adrenal hyperplasia: beyond conventional glucocorticoid therapy
    Khattab, Ahmed
    Marshall, Ian
    CURRENT OPINION IN PEDIATRICS, 2019, 31 (04) : 550 - 554
  • [37] Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue
    Halper, Alyssa
    Sanchez, Belen
    Hodges, James S.
    Dengel, Donald R.
    Petryk, Anna
    Sarafoglou, Kyriakie
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 124 - 130
  • [38] Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia
    Ganesh, Ramaswamy
    Suresh, Natarajan
    Janakiraman, Lalitha
    Ravikumar, Karnam
    INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (02): : 126 - 130
  • [39] Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia
    Ramaswamy Ganesh
    Natarajan Suresh
    Lalitha Janakiraman
    Karnam Ravikumar
    The Indian Journal of Pediatrics, 2016, 83 : 126 - 130
  • [40] Bone density in young patients with congenital adrenal hyperplasia
    Mora, S
    Saggion, F
    Russo, G
    Weber, G
    Bellini, A
    Prinster, C
    Chiumello, G
    BONE, 1996, 18 (04) : 337 - 340